Department of Family Medicine and Public Health Sciences, School of Medicine, Wayne State University, Detroit, MI.
Department of Oncology, School of Medicine, Wayne State University, Detroit, MI.
Urology. 2021 Sep;155:83-90. doi: 10.1016/j.urology.2020.12.037. Epub 2021 Jan 19.
To assess practicing urologists' attitudes and perceptions of active surveillance (AS) and other treatment options for low-risk prostate cancer.
This was a cross-sectional survey of urologists practicing in Michigan and Georgia. Urologists were asked about perceptions and practices pertaining to AS.
Overall, 225 urologists completed the survey; 147 (65%) were from Michigan and 78 (35%) were from Georgia. Most urologists reported they provided (99%), discussed (97%), and offered (61%) AS to all of their low-risk patients. Most believed AS is effective (97%) and underused (90%), while 80% agreed that curative therapy (surgery, radiation) is overused in the United States. Although most (79%) endorse that Black men are more likely to have aggressive low-risk disease, 89% reported feeling comfortable recommending AS to Black men. In multivariable analysis, significant provider-related predictors of AS recommendation were practice location, number of years in practice, beliefs pertaining to survival benefit of prostatectomy and effectiveness of AS, and expectation that patients are not interested in AS. The patient characteristics of race, age, life expectancy, fear of cancer progression, and fear of treatment side effects were also significant predictors of AS recommendations.
Most urologists surveyed stated that AS is effective and underused for low-risk prostate cancer . Overall, urologists are much less likely to recommend AS to younger men and slightly less to Black men. AS recommendations varied by practice location and by years in practice. These findings indicate targeted educational efforts in the US are needed to influence urologists toward greater acceptance of AS.
评估泌尿科医生对主动监测(AS)和其他低危前列腺癌治疗选择的态度和看法。
这是一项针对密歇根州和佐治亚州的泌尿科医生的横断面调查。泌尿科医生被问及与 AS 相关的看法和实践。
共有 225 名泌尿科医生完成了调查;147 名(65%)来自密歇根州,78 名(35%)来自佐治亚州。大多数泌尿科医生报告称,他们向所有低危患者提供(99%)、讨论(97%)和提供(61%)AS。大多数人认为 AS 有效(97%)且使用不足(90%),而 80%的人同意美国的根治性治疗(手术、放疗)过度使用。尽管大多数人(79%)认为黑人男性更有可能患有侵袭性低危疾病,但 89%的人表示愿意向黑人男性推荐 AS。多变量分析显示,推荐 AS 的显著提供者相关预测因素包括实践地点、从业年限、对前列腺切除术生存获益和 AS 有效性的信念,以及患者对 AS 不感兴趣的预期。种族、年龄、预期寿命、对癌症进展的恐惧和对治疗副作用的恐惧等患者特征也是 AS 推荐的重要预测因素。
大多数接受调查的泌尿科医生表示,AS 对低危前列腺癌有效且使用不足。总体而言,泌尿科医生不太可能向年轻男性和黑人男性推荐 AS。AS 的推荐因实践地点和从业年限而异。这些发现表明,美国需要有针对性的教育努力,以影响泌尿科医生更广泛地接受 AS。